IL109761A0 - Oligopeptides derived from c-reactive protein fragments - Google Patents

Oligopeptides derived from c-reactive protein fragments

Info

Publication number
IL109761A0
IL109761A0 IL10976194A IL10976194A IL109761A0 IL 109761 A0 IL109761 A0 IL 109761A0 IL 10976194 A IL10976194 A IL 10976194A IL 10976194 A IL10976194 A IL 10976194A IL 109761 A0 IL109761 A0 IL 109761A0
Authority
IL
Israel
Prior art keywords
pct
reactive protein
protein fragments
oligopeptides derived
derived
Prior art date
Application number
IL10976194A
Other languages
English (en)
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of IL109761A0 publication Critical patent/IL109761A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10976194A 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments IL109761A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Publications (1)

Publication Number Publication Date
IL109761A0 true IL109761A0 (en) 1994-08-26

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10976194A IL109761A0 (en) 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments

Country Status (19)

Country Link
US (1) US6057295A (fr)
EP (1) EP0723552B1 (fr)
JP (1) JP3221881B2 (fr)
KR (1) KR100363408B1 (fr)
CN (1) CN1041524C (fr)
AT (1) ATE226591T1 (fr)
AU (1) AU684511B2 (fr)
CA (1) CA2173939C (fr)
DE (1) DE69431603T2 (fr)
DK (1) DK0723552T3 (fr)
ES (1) ES2185652T3 (fr)
FI (1) FI961584L (fr)
HU (1) HUT75538A (fr)
IL (1) IL109761A0 (fr)
IT (1) IT1271486B (fr)
NO (1) NO961423L (fr)
PT (1) PT723552E (fr)
WO (1) WO1995010531A1 (fr)
ZA (1) ZA943610B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (fr) * 2002-10-09 2004-04-14 3 D Gene Pharma Derivés de pyrolidine comme médicaments contre Hepatitis C
EP2898900B1 (fr) 2008-09-19 2017-11-15 Nektar Therapeutics Conjugués polymères de ziconotide
ES2678143T3 (es) 2010-01-19 2018-08-09 President And Fellows Of Harvard College Opsonina obtenida por ingeniería genética para la detección y el tratamiento de microorganismos patógenos
EP2734843A2 (fr) 2011-07-18 2014-05-28 President and Fellows of Harvard College Molécules manipulées ciblant un microbe et leurs utilisations
EP2976642A4 (fr) 2013-03-15 2016-09-21 Harvard College Procédés et compositions pour améliorer la détection et/ou la capture d'une entité cible
US9988617B2 (en) 2013-05-21 2018-06-05 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (fr) 2013-12-18 2021-07-07 President and Fellows of Harvard College Capture/détection de bactéries gram positif à l'aide de crp
CN108289928B (zh) 2015-08-06 2024-09-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0253190B1 (fr) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Analogues de la tuftsine partiellement rétro-inversés, leur méthode de préparation et compositions pharmaceutiques les contenant
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
WO1995010531A1 (fr) 1995-04-20
CA2173939A1 (fr) 1995-04-20
ITMI932154A0 (it) 1993-10-12
NO961423D0 (no) 1996-04-11
FI961584A7 (fi) 1996-04-11
AU6844194A (en) 1995-05-04
IT1271486B (it) 1997-05-28
NO961423L (no) 1996-06-10
FI961584A0 (fi) 1996-04-11
HUT75538A (en) 1997-05-28
CA2173939C (fr) 2002-08-27
CN1041524C (zh) 1999-01-06
DE69431603T2 (de) 2003-03-13
ATE226591T1 (de) 2002-11-15
FI961584L (fi) 1996-04-11
JP3221881B2 (ja) 2001-10-22
AU684511B2 (en) 1997-12-18
EP0723552B1 (fr) 2002-10-23
ITMI932154A1 (it) 1995-04-12
KR100363408B1 (ko) 2003-02-11
DK0723552T3 (da) 2003-02-24
DE69431603D1 (de) 2002-11-28
CN1133048A (zh) 1996-10-09
EP0723552A1 (fr) 1996-07-31
HU9600934D0 (en) 1996-08-28
ZA943610B (en) 1995-01-25
ES2185652T3 (es) 2003-05-01
US6057295A (en) 2000-05-02
PT723552E (pt) 2003-02-28
JPH09503200A (ja) 1997-03-31

Similar Documents

Publication Publication Date Title
WO1998033509A3 (fr) Proprietes utiles de la lactoferrine humaine et de variants de celle-ci
CA2395266A1 (fr) Utilisation de subtilisines stables en milieu acide dans des aliments pour animaux
WO1998026747A3 (fr) Procedes et compositions de traitement de maladies a base de superantigenes
GR3035440T3 (en) Therapeutic uses of bpi protein products for human meningococcemia
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
WO1996017935A3 (fr) Peptide rantes et fragments et compositions comprenant ce peptide, pour le traitement de l'inflammation
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
AU3477295A (en) Modified proteins
HU9600934D0 (en) Oligopeptides derived from c-reactive protein fragments
DE69420145D1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
AU1384995A (en) Human circulating cytokine cc-1
DE69534753D1 (de) Nierenpolycystose-gen
CA2136841A1 (fr) Nouveaux piperidylamides, sulfonamides et sulfoxamides utilisees comme inhibiteurs de la biosynthese du cholesterol
GB2374871A (en) Peptide fragments of colostrinin and their use
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
AU3095989A (en) Modified proteins
ZA932748B (en) Water-soluble retinoids
EP1671646A3 (fr) Procédés de traitement de troubles associés à IgE et compositions pouvant être utilisées à cet effet.
BG102937A (en) Zona pelucida proteins as contraceptives
GB9723824D0 (en) Cytostatic agents
LT2001045A (en) Compositions and use thereof for downmodulating the immune response to therapeutic proteins
AU1879097A (en) Fragments of cr1 and their use
AU1507300A (en) Pharmaceutical compositions containing proteins
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
AU5382598A (en) N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions